Xiaohui Wei

Title: Innovations of Xiaohui Wei in Biopharmaceuticals

Introduction

Xiaohui Wei is a notable inventor based in Shanghai, China, recognized for his contributions to the field of biopharmaceuticals. He holds 2 patents that showcase his innovative approaches to drug delivery and imaging techniques.

Latest Patents

Wei's latest patents include an irinotecan liposome preparation and an aqueous negative contrast medium for CT imaging of the gastrointestinal tract. The irinotecan liposome preparation involves a unique formulation where irinotecan is encapsulated in an internal aqueous phase of a liposome, which enhances its sustained-release effect. This innovative method utilizes a sulfonate gradient to improve the drug's efficacy. The second patent focuses on a negative contrast agent designed for CT imaging, which is composed of a hydrogel matrix and low-density micro-/nano-particles. This agent significantly improves the clarity of CT images of the gastrointestinal tract, making it a valuable tool for diagnosing intestinal diseases.

Career Highlights

Throughout his career, Xiaohui Wei has worked with various organizations, including Highfield Biopharmaceutical Corporation. His work has significantly impacted the development of advanced pharmaceutical formulations and imaging techniques.

Collaborations

Wei has collaborated with notable colleagues, including Yuhong Xu and Jianrong Xu, contributing to the advancement of biopharmaceutical research.

Conclusion

Xiaohui Wei's innovative patents and career achievements highlight his significant contributions to the field of biopharmaceuticals. His work continues to influence advancements in drug delivery and medical imaging technologies.